New York State Common Retirement Fund
SGMO

New York State Common Retirement Fund’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

New York State Common Retirement Fund’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,337
Closed -$479 – 3317
2024
Q2 		$479 Sell
1,337
-38,653
-97% -$20.9K ﹤0.01% 3341
2024
Q1 		$26.8K Sell
39,990
-391
-1% -$284 ﹤0.01% 3111
2023
Q4 		$21.9K Sell
40,381
-335
-0.8% -$154 ﹤0.01% 3143
2023
Q3 		$24.4K Buy
40,716
+616
+2% +$660 ﹤0.01% 3165
2023
Q2 		$52.1K Sell
40,100
-274
-0.7% -$374 ﹤0.01% 3123
2023
Q1 		$71.1K Sell
40,374
-40,123
-50% -$115K ﹤0.01% 2902
2022
Q4 		$253K Buy
80,497
+47
+0.1% +$182 ﹤0.01% 2629
2022
Q3 		$394K Buy
80,450
+198
+0.2% +$1.02K ﹤0.01% 2455
2022
Q2 		$332K Sell
80,252
-4,491
-5% -$19.4K ﹤0.01% 2550
2022
Q1 		$492K Buy
84,743
+62
+0.1% +$369 ﹤0.01% 2411
2021
Q4 		$635K Sell
84,681
-29,778
-26% -$259K ﹤0.01% 2319
2021
Q3 		$1.03M Buy
114,459
+638
+0.6% +$6.31K ﹤0.01% 2098
2021
Q2 		$1.36M Sell
113,821
-11,850
-9% -$134K ﹤0.01% 2079
2021
Q1 		$1.57M Hold
125,671
– – ﹤0.01% 1922
2020
Q4 		$1.96M Buy
125,671
+14,350
+13% +$168K ﹤0.01% 1705
2020
Q3 		$1.05M Hold
111,321
– – ﹤0.01% 1881
2020
Q2 		$997K Buy
111,321
+10,500
+10% +$97.4K ﹤0.01% 1872
2020
Q1 		$642K Buy
100,821
+100
+0.1% +$742 ﹤0.01% 1933
2019
Q4 		$843K Sell
100,721
-24,400
-20% -$224K ﹤0.01% 2038
2019
Q3 		$1.13M Buy
125,121
+1,200
+1% +$13.5K ﹤0.01% 1939
2019
Q2 		$1.33M Buy
123,921
+17,600
+17% +$187K ﹤0.01% 1862
2019
Q1 		$1.01M Sell
106,321
-450
-0.4% -$4.6K ﹤0.01% 1957
2018
Q4 		$1.23M Sell
106,771
-14,150
-12% -$176K ﹤0.01% 1801
2018
Q3 		$2.05M Buy
120,921
+500
+0.4% +$7.6K ﹤0.01% 1668
2018
Q2 		$1.71M Buy
120,421
+20,500
+21% +$341K ﹤0.01% 1784
2018
Q1 		$1.9M Buy
99,921
+850
+0.9% +$18.2K ﹤0.01% 1660
2017
Q4 		$1.63M Sell
99,071
-14,159
-13% -$211K ﹤0.01% 1763
2017
Q3 		$1.7M Buy
113,230
+37,030
+49% +$409K ﹤0.01% 1734
2017
Q2 		$671K Buy
76,200
+12,699
+20% +$81.5K ﹤0.01% 2268
2017
Q1 		$330K Sell
63,501
-26,349
-29% -$106K ﹤0.01% 2583
2016
Q4 		$274K Hold
89,850
– – ﹤0.01% 2655
2016
Q3 		$416K Hold
89,850
– – ﹤0.01% 2401
2016
Q2 		$520K Buy
89,850
+26,350
+41% +$168K ﹤0.01% 2263
2016
Q1 		$384K Hold
63,500
– – ﹤0.01% 2357
2015
Q4 		$580K Hold
63,500
– – ﹤0.01% 2240
2015
Q3 		$358K Sell
63,500
-9,251
-13% -$76.3K ﹤0.01% 2469
2015
Q2 		$807K Buy
+72,751
New +$938K ﹤0.01% 2298

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

New York State Common Retirement Fund's SGMO Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 1,337 shares — an estimated $479 sold.

New York State Common Retirement Fund first reported a position in SGMO in Q2 2015 and held it in 37 quarters. The position peaked at $2.05M in Q3 2018. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,337 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $479.
  • New York State Common Retirement Fund first reported a position in SANGAMO THERAPEUTICS INC in Q2 2015 and held it in 37 quarters.
  • New York State Common Retirement Fund's SANGAMO THERAPEUTICS INC position peaked at $2.05M in Q3 2018.
  • 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.